HAMPLATIN
DEAD

Serial Number

86480624

Owner

MedOC Pharmaceutical Co., Ltd.

Attorney

Timothy T. Wang

First Use Date

May 10, 2016

Filing Date

Dec 15, 2014

Add to watchlist:

No watchlists yet
View on USPTO

HAMPLATIN Trademark

Serial Number: 86480624 • Registration: 5171990

HAMPLATIN is a trademark filed by MedOC Pharmaceutical Co., Ltd. on December 15, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MedOC Pharmaceutical Co., Ltd. (2 trademarks)

No. 229 Guyuan Rd
Changsha, Hunan , CN

Entity Type: 99

Trademark Details

Filing Date

December 15, 2014

Registration Date

March 28, 2017

First Use Anywhere

May 10, 2016

First Use in Commerce

May 10, 2016

Published for Opposition

June 7, 2016

Cancellation Date

October 13, 2023

Goods & Services

Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes

Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 13, 2023 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 28, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 22, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 21, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 15, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 11, 2017 AITU
USE AMENDMENT FILED
Jan 25, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 25, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2015 GNRN
NON-FINAL ACTION E-MAILED
Oct 27, 2015 GNRT
NON-FINAL ACTION WRITTEN
Oct 27, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2015 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2015 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2015 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2015 TCCA
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2014 NWOS
NEW APPLICATION ENTERED
Dec 18, 2014 NWAP